Von Willebrand Factor and Hematogenous Cancer Metastasis Under Flow

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2024 Sep 16

PMID 39282473

Authors

Wenxuan Xu

Xi Tan

Morgan L Li

Hanzhi Xu

Jasmine Villegas

Hongxia Fu

Affiliations

Soon will be listed here.

Abstract

Hematogenous metastasis involves cancer cell migration to different locations from the primary tumor through the blood circulation. Von Willebrand factor (VWF) has been shown to play an important role in tumor cell adhesion to and extravasation from the endothelial cell lining of blood vessel walls during cancer metastasis. VWF may contribute to this process by interacting with tumor cells, endothelial cells, and platelets through various cell membrane receptors, such as platelet glycoprotein (GP)Ibα, P-selectin, αβ and αβ integrins, and glycocalyx. Blood flow can mechanically extend and activate VWF to bind platelets and associate intermolecularly with other VWF molecules in plasma or on the surface of endothelial cells, cancer cells, or platelets. This suggests a mechanoregulatory role of VWF in mediating the interactions between VWF and these cells to promote cancer cell adhesion to blood vessels. In this review, we will summarize the current knowledge of VWF function and the role of hydrodynamic forces in hematogenous cancer metastasis.

References

Dong X, Leksa N, Seth Chhabra E, Arndt J, Lu Q, Knockenhauer K . The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis. Blood. 2019; 133(14):1523-1533. PMC: 6450429. DOI: 10.1182/blood-2018-10-876300. View

Ying J, Ling Y, Westfield L, Sadler J, Shao J . Unfolding the A2 domain of von Willebrand factor with the optical trap. Biophys J. 2010; 98(8):1685-93. PMC: 2856187. DOI: 10.1016/j.bpj.2009.12.4324. View

Shamay Y, Elkabets M, Li H, Shah J, Brook S, Wang F . P-selectin is a nanotherapeutic delivery target in the tumor microenvironment. Sci Transl Med. 2016; 8(345):345ra87. PMC: 5064151. DOI: 10.1126/scitranslmed.aaf7374. View

Kawecki C, Lenting P, Denis C . von Willebrand factor and inflammation. J Thromb Haemost. 2017; 15(7):1285-1294. DOI: 10.1111/jth.13696. View

Nishida N, Sumikawa H, Sakakura M, Shimba N, Takahashi H, Terasawa H . Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment. Nat Struct Biol. 2002; 10(1):53-8. DOI: 10.1038/nsb876. View

Terraube V, Pendu R, Baruch D, Gebbink M, Meyer D, Lenting P . Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost. 2006; 4(3):519-26. DOI: 10.1111/j.1538-7836.2005.01770.x. View

Karpatkin S, Pearlstein E, Ambrogio C, Coller B . Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest. 1988; 81(4):1012-9. PMC: 329625. DOI: 10.1172/JCI113411. View

Ulrichts H, Vanhoorelbeke K, Girma J, Lenting P, Vauterin S, Deckmyn H . The von Willebrand factor self-association is modulated by a multiple domain interaction. J Thromb Haemost. 2005; 3(3):552-61. DOI: 10.1111/j.1538-7836.2005.01209.x. View

Verheul H, Jorna A, Hoekman K, Broxterman H, Gebbink M, Pinedo H . Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood. 2000; 96(13):4216-21. View

10.

Papaioannou T, Stefanadis C . Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol. 2005; 46(1):9-15. View

11.

Eppert K, Wunder J, Aneliunas V, Kandel R, Andrulis I . von Willebrand factor expression in osteosarcoma metastasis. Mod Pathol. 2004; 18(3):388-97. DOI: 10.1038/modpathol.3800265. View

12.

Follain G, Osmani N, Azevedo A, Allio G, Mercier L, Karreman M . Hemodynamic Forces Tune the Arrest, Adhesion, and Extravasation of Circulating Tumor Cells. Dev Cell. 2018; 45(1):33-52.e12. DOI: 10.1016/j.devcel.2018.02.015. View

13.

Lonsdorf A, Kramer B, Fahrleitner M, Schonberger T, Gnerlich S, Ring S . Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J Biol Chem. 2011; 287(3):2168-78. PMC: 3265895. DOI: 10.1074/jbc.M111.269811. View

14.

Sadler J . Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998; 67:395-424. DOI: 10.1146/annurev.biochem.67.1.395. View

15.

Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano H . Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. J Natl Cancer Inst. 2012; 104(12):906-22. DOI: 10.1093/jnci/djs232. View

16.

Dagil L, Troelsen K, Bolt G, Thim L, Wu B, Zhao X . Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor. Biophys J. 2019; 117(3):479-489. PMC: 6697466. DOI: 10.1016/j.bpj.2019.07.007. View

17.

Brondijk T, Bihan D, Farndale R, Huizinga E . Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex. Proc Natl Acad Sci U S A. 2012; 109(14):5253-8. PMC: 3325688. DOI: 10.1073/pnas.1112388109. View

18.

Bonnefoy A, Romijn R, Vandervoort P, VAN Rompaey I, Vermylen J, Hoylaerts M . von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Haemost. 2006; 4(10):2151-61. DOI: 10.1111/j.1538-7836.2006.02111.x. View

19.

Yee A, Oleskie A, Dosey A, Kretz C, Gildersleeve R, Dutta S . Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII. Blood. 2015; 126(8):939-42. PMC: 4543228. DOI: 10.1182/blood-2015-04-641696. View

20.

Ju L, Dong J, Cruz M, Zhu C . The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα. J Biol Chem. 2013; 288(45):32289-32301. PMC: 3820866. DOI: 10.1074/jbc.M113.504001. View